O
CPRX icon

OrbiMed’s Catalyst Pharmaceutical CPRX Stock Holding History

OrbiMed’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-416,900
Closed -$9.05M – 116
2025
Q2 		$9.05M Buy
+416,900
New +$9.84M 0.23% 62
2018
Q4 		– Sell
-1,102,000
Closed -$4.17M – 136
2018
Q3 		$4.17M Buy
+1,102,000
New +$3.45M 0.05% 131
2014
Q3 		– Sell
-1,895,000
Closed -$4.79M – 136
2014
Q2 		$4.79M Hold
1,895,000
– – 0.06% 111
2014
Q1 		$4.28M Hold
1,895,000
– – 0.05% 121
2013
Q4 		$3.69M Hold
1,895,000
– – 0.06% 103
2013
Q3 		$5.78M Buy
+1,895,000
New +$3.19M 0.11% 97

Other funds holding CPRX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return